In poor prognostic breast cancer, TSPYL5 promotes the degradation of the p53 tumor suppressor by directly inhibiting ubiquitin carboxyl-terminal hydrolase 7 (USP7), a p53 deubiquitinase23. The gene discussed is USP7; the disease is breast cancer.